|

Big picture: What’s the reason for stock market uncertainty

There has been a steady rise in neutral sentiment towards the direction of stocks. So, it is important to understand why that is.

The reason for indecision

The Fed has recently communicated two things clearly. Firstly, that interest rates must rise to combat inflation. Secondly, the pace is likely to slow, but the terminal rate could be higher than previously expected. The Fed has also said that it will be data-dependent going forward, so that means a constant push and pull from stocks as incoming data suggests peak inflation and the next piece suggest stickier inflation.

The latest run of data

US Core PCE last week showed that inflation still remains fairly high. Core PCE y/y stayed at 5% and the prior reading of 5.1% was revised higher to 5.2%. Hardly peak inflation here.

PCE

US ISM data last week printed lower than expected with prices coming in lower than even the lowest projections at 43. So, slowing US growth should mean slower and lower Fed rates (bullish stocks and negative USD). However, then Friday’s jobs reports contradicted the drop in manufacturing prices for November.

Last Friday’s NFP showed a higher than forecasted headline print of 263K and average hourly earnings were much higher at 5.1% vs 4.6% expected. The prior reading was slowly revised higher to 4.9%. This would potentially worry the Fed that there is a wage-price spiral underway.

Chart

Then yesterday the latest US Services PMI print came in strong and that affirms that the Fed could hike rates even higher if it needed to.

So, this means that the path for the pace and extent of Fed rates is uncertain in the current climate. But it means that medium-term/long-term traders may pay to be more patient. Short-term traders can continue to trade the different data points from the US as they indicate different narratives about the speed and extent of Fed hikes. Slower, and lower US rates should weaken the USD and support US stocks and gold. Faster, and higher US rates should strengthen the USD, but weaken stocks and gold.


Learn more about HYCM


Author

Giles Coghlan LLB, Lth, MA

Giles is the chief market analyst for Financial Source. His goal is to help you find simple, high-conviction fundamental trade opportunities. He has regular media presentations being featured in National and International Press.

More from Giles Coghlan LLB, Lth, MA
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.